NCT06274424

Brief Summary

This study aims to examine the relationship between hair cortisol concentration and behavior and sleep disturbance symptoms in children with psychiatric disorders. It also investigates potential changes in hair cortisol and symptomatology after group-based cognitive behavior therapy. Furthermore, the study explores the effects of any alterations in hair cortisol concentration levels on potential behavior and sleep disturbance symptom change over the course of the study.

Trial Health

100
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
100

participants targeted

Target at P50-P75 for not_applicable

Timeline
Completed

Started Jul 2016

Longer than P75 for not_applicable

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

July 1, 2016

Completed
3.3 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

October 1, 2019

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

October 1, 2019

Completed
4.4 years until next milestone

First Submitted

Initial submission to the registry

February 16, 2024

Completed
7 days until next milestone

First Posted

Study publicly available on registry

February 23, 2024

Completed
Last Updated

February 29, 2024

Status Verified

February 1, 2024

Enrollment Period

3.3 years

First QC Date

February 16, 2024

Last Update Submit

February 27, 2024

Conditions

Keywords

Childrengroup cognitive behavioral therapyhair cortisol concentrationinternalizing symptomsexternalizing symptomssleep disturbance symptoms

Outcome Measures

Primary Outcomes (4)

  • Hair Cortisol Concentration

    Level of hair cortisol concentration measured from hair samples

    Before and after the group cognitive behavioral intervention (duration from pre-GCBT to post-GCBT circa 4.7 months), and at a 7-month follow-up

  • Parent- and teacher rated internalizing and externalizing symptoms

    The Achenbach System of Empirically Based Assessment (ASEBA). Scores below 60 reflect the normal range, scores from 60 to 63 the borderline range, and scores above 63 the clinical range

    Before and after the group cognitive behavioral intervention (duration from pre-GCBT to post-GCBT circa 4.7 months), and at a 7-month follow-up

  • Child-rated internalizing symptoms

    The Spence Children´s Anxiety Scale. A total score of 60 or higher is indicative of elevated anxiety.

    Before and after the group cognitive behavioral intervention (duration from pre-GCBT to post-GCBT circa 4.7 months), and at a 7-month follow-up

  • Parent-rated sleep disturbance symptoms

    Sleep Disturbance Scale for Children (SDSC). A cutoff score of 39 and above has been suggested to identify children with sleep disturbance.

    Before and after the group cognitive behavioral intervention (duration from pre-GCBT to post-GCBT circa 4.7 months), and at a 7-month follow-up

Study Arms (1)

Group Cognitive Behavioral Therapy Intervention

EXPERIMENTAL

The Friends Program

Behavioral: The Friends Program

Interventions

A group CBT intervention comprising ten weekly 60-minute sessions followed by two booster sessions.

Group Cognitive Behavioral Therapy Intervention

Eligibility Criteria

Age6 Years - 13 Years
Sexall
Healthy VolunteersNo
Age GroupsChild (0-17)

You may qualify if:

  • symptoms of anxiety or depression
  • deficiencies in emotional and behavioral skills impairing functioning
  • sufficient social and cognitive skills to participate in group work.

You may not qualify if:

  • excessive physical aggression
  • excessive physical restlessness
  • severity of psychiatric symptoms requiring individual psychotherapy (e.g., acute suicidality).

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Design

Study Type
interventional
Phase
not applicable
Allocation
NA
Masking
NONE
Purpose
TREATMENT
Intervention Model
SINGLE GROUP
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Principal Investigator

Study Record Dates

First Submitted

February 16, 2024

First Posted

February 23, 2024

Study Start

July 1, 2016

Primary Completion

October 1, 2019

Study Completion

October 1, 2019

Last Updated

February 29, 2024

Record last verified: 2024-02

Data Sharing

IPD Sharing
Will not share